Stockreport

Sangamo And Biogen Tie Up, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]

Nevro Corp.  (NVRO) 
Last nevro corp. earnings: 2/25 04:10 pm Check Earnings Report
PDF SummarySangamo and Biogen initiated a global licensing deal.AstraZeneca received FDA approval for Selumetinib.Boston Scientific lost a patent lawsuit.Sangamo Closes Gene [Read more]